← Back to context

Comment by BugsJustFindMe

3 days ago

https://archive.ph/cg4we

I do not like UnitedHealth, I do not like our existing crop of health insurance executives, and I might even be viscerally glad at some level that the UnitedHealth CEO was killed in a world where justice clearly takes a back seat to greed, but I wish the headline didn't say "overcharged", because there's no established amount of markup that is the correct amount of markup other than what people end up paying. Is that shitty? Yes. Does it violate a social contract? I think so. But tell me how much the right amount to charge is first. Is that cost? Cost+percentage? They've chosen their percentage. What's the correct one instead?

The article body presents the story in a more meaningful way, "UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ten or more".

All I'm going to say is that Optum Specialty Pharmacy is the sole source that UHC will accept for a lot of special drugs. For example UHC offers insurance for IVF including a separate cap for medications, but if you use their insurance you have to order through their subsidiary Optum Specialty Pharmacy and the prices triple or quadruple over MSRP if you buy from OSP using insurance versus if you pay cash. They also won't tell you this until you're in the middle of a cycle and an order gets held up because you're out of insurance, but since they billed insurance you're on the hook for the remaining several-thousand dollars because if you stop the drugs you're just out the money and the medication and have to wait another month.

I don't know if I can give them the benefit of the doubt on the cancer drugs because of this.

  • > subsidiary Optum Specialty Pharmacy and the prices triple or quadruple over MSRP if you buy from OSP using insurance versus if you pay cash.

    As an European, this is mind boggling.

  • I don't want you to give them the benefit of the doubt. I certainly don't think they deserve it. I do think, however, that a conversation about "overcharging" goes nowhere until people talk about exactly where charging ends and overcharging begins.

    • I'd be fine with a 20-50% markup on MSRP to cover billing and administration costs but when the insurer owns the pharmacy they can "negotiate" whatever rate they want and you have to pay it. I don't see it directly in the article, but I suspect they do the same thing with cancer drugs as with IVF drugs and require you to go through their pharmacy for insurance coverage. Insurance plans often have lifetime maximums, and when they set their own prices and collect money from themselves for the medication they sell you they can basically dictate how much actual coverage you get versus someone paying cash. And because you chose "bill insurance" when you ordered the medication, you're now on the hook for whatever additional cost there was versus the cash price. And also they won't tell you what the cost is until after the medication has already shipped.

      So it's at least plausible that they're abusing their position as the company that owns the pharmacy and the insurance plan to charge you a lot of money and provide very little coverage and also to gouge you at the very end of your coverage, because that's exactly what they did to my partner and I.

      2 replies →

    • Anything above what Medicaid pays for drugs/procedures (and maybe a few % over to account for health insurance salaries) is overcharging.

      Is that clear enough for you?

      3 replies →

  • UHC double-dips because they own Optum even though Optum is "independent". It's fucking disgusting. How they were allowed to buy Optum and didn't have every regulator in the country on the case is beyond me.

    I $truggle to think how $omething like thi$ wa$ allowed to happen.

    Bastards.

    • My wife had to quit seeing her doctor of many years a couple of years ago because as Optum has been devouring practices in our area, they stuck her with a surprise bill almost a decade ago and then fired her as a patient without providing even a statement. Now that they own her doctor she can no longer go to that practice even though she was a paying patient for many years.

      1 reply →

    • You have that a little mixed up. Both UnitedHealthcare (UHC) and Optum are subsidiaries of UnitedHealth Group (UHG). UHC never bought Optum. Some parts of Optum were spun out of UHC's IT department so that they could commercialize software they had developed for internal use and sell it to other customers (including some of UHC's competitors in the commercial payer space). Other parts of Optum were acquired or created internally. What is now OptumRx (the PBM) was originally PacifiCare Health Systems. UHG acquired that business way back in 2005 before the Optum brand even existed.

      I agree that more reform and enforcement is needed in the healthcare industry but let's at least get the facts and history right.

I take issue with the claim that in order to say something is too expensive that you must be able to precisely propose an alternative price.

I have no idea what the correct margin for essential cancer drugs is. I don’t think it should be a 10x markup. Intuitively, it seems that there’s something wrong with price gouging dying cancer patients. If you have an argument why my intuition is wrong, please share it.

  • > I take issue with the claim that in order to say something is too expensive that you must be able to precisely propose an alternative price.

    If you want to be quantitative of course you do. How hard is it? Margin of error is allowed. If you want to be qualitative, vague and wishy washy, that has its place too, but at some point someone is going to ask for a quantitative assertion, otherwise you get nowhere.

    • To use a software development analogy, the average person is a user of health care, not a health care project manager or designer.

      Just as the user of an App doesn't need to provide an alternative design when they say "this App sucks", the average user of healthcare likewise has no obligation to redesign the healthcare system when they say "this healthcare system sucks."

      7 replies →

    • "overcharge" is a qualitative source. If you're not working in the economics, I don't see much worth in finding the exact line between such a qualitative word. The market has some intuitiveness and know that charging 30$ for an item that costs $3 to make is highway robbery. Doesn't matter when or if we start to agree that $5, $6, or even $10 is reasonable (and yes, these are all pretty high markups to begin with compared to typical markups for stores).

      We don't need to find the touchdown line when we're already outside of the stadium and the parking lot anyway.

  • > I have no idea what the correct margin for essential cancer drugs is.

    So let's talk about it and think about it and form an idea. There's no universally right or wrong answer, but you should at least be able to decide what answer is right to you.

    > I don’t think it should be a 10x markup.

    What about 1x markup?

    > Intuitively, it seems that there’s something wrong with price gouging

    There is, but you're relying on the word "gouging", and without identifying what price you think is gouging vs reasonable profit, stopping at the point where you express that "too much is too much" doesn't get us any closer to having actionable goals.

    • So, important question: What problem are we trying to solve here? Is there any benefit to the overall populace for us in HN to debate what we feel is "overcharged"?

      ----

      But to go along with your exercise, I take a look at current market dynamics and compare it from there. Apparently, the typical wholesale markup is 20-40%, and stores will typically markup another 20-50% on top of that. So we're talking roughly a 125% markup on the higher ends from the factory into the consumer's hands as a very rough average (VERY rough, markups vary a lot per product and industry).

      That's with two chains of markup, so clearly 1000% feels absurd from one part of such a chain. Outside of factors like drinks (which are easy to scale and can have markups well into the hundreds), it's pretty hard to find any part of the chain as not "overcharged" once we go past 100% markups in any given place.

      on the most generous side, Costco famously has markups limited to 14% (albeit they rely on bulk purchases to mitigate that). and subsidized vehicles used to generally be a 10-15% markup price. So I'd say 15% is about the bare bottom of what to expect markups without some kind of twist. e.g. printers selling at a loss, making up for it with high markups for ink (another product that's easy to scale and marked up into the hundreds). or previously, a video game console in order to sell games (software, whose markup is hard to really determine since it's infinitely scalable and costs are more to make up for R&D).

      3 replies →

They've chosen 90% margin (cost + 1000%).

Semicon tool builders (my industry) have margins around 50% (cost + 100%). This is considered high margin manufacturing work.

To match United Health's margins we'd need to raise prices by 5x.

  • I agree, but we can't talk about "over" without talking about where the line is.

    • Sure we can.

      Some loaves of bread are worth a dollar. Some are worth ten dollars. The exact line is hard to pin down... but a $1,000 loaf of bread is probably excessive.

    • This is semantic nitting and wastes time when for all practical intents and purposes humans understand the assertion being made and find it agreeable.

    • You can talk about jetliners cruising over towns without discussing the height of a town's buildings. No one here seems to be in disagreement that the line is lower, which is all we need to know to describe the markup as over.

    • Fundamentally, you have a pretty good point here, since the system we have has two halves that are fundamentally at odds:

      One part "free market -- maximize your profits as much as you can and get rewarded by a skyrocketing share price!"

      And one part, unspoken except in the PR BS put out by the insurance companies, "Try to improve the health of patients and have them not die!"

      The only way the two can coexist at all is if someone draws some lines like you are suggesting. I know that there are some (probably easily manipulated) laws stating that X% of premiums have to be "spent on care" and if they get too high overall margins on your group, they have to give your employer a rebate. Of course, who knows whether you'll see that money.

      If we just say "maximize your profits" (and indeed, shareholders 'should' sue them if they don't) then it's obvious that morally bankrupt scum that runs all these insurers would 100% extort people for 1000% profits on lifesaving drugs. It's the most logical course of action! People will pay infinity dollars to save their own lives/their loved ones, so let's soak them!

      If it's not obvious, I believe that overall the "free market" part of this system is a failed experiment that should be abolished immediately, and not just because I want all of these companies' sickening, greedy executives to go straight to hell (where Brian Thompson is burning today).

      6 replies →

The article is about UnitedHealth's PBM, which negotiates rates and then earns revenue from drug manufacturers through rebates. Remember that insurance is part of Big Finance and involves a lot of clever instruments to shuffle around money, risk, and accountability. PBM's are one of those instruments. Our intuitive Econ 101 models of the industry don't always go far enough into the weeds when we're just reacting to headlines. This is one of those occasions.

https://content.naic.org/insurance-topics/pharmacy-benefit-m...

  • For those who want to really understand the impact that PMBs play on the overall US healthcare system I highly recommend reading the "The Price We Pay: What Broke American Health Care--and How to Fix It" by Marty Makary, MD. The system of legalized kickbacks that they use isn't widely recognized but it will have to be reformed if we ever want to bring down prescription drug spending.

    https://www.bloomsbury.com/us/price-we-pay-9781635575910/

This is exactly it. They are charging that price because that price will be paid, and this maximizes their overall profit. In other similar situations this would spur competition, which would ultimately drive down prices to a reasonable level. But in the healthcare industry competition is often prohibited or made very difficult by law. You can cite the patent system as an example of this, but another horrible one is the "certificate of need" laws, which should infuriate you.

> there's no established amount of markup that is the correct amount of markup other than what people end up paying.

Of course it's all subjective, but I cannot think of a single other industry that can get away with a 1000% markup on anything and expect to get away with it. In proper capitalism, that just means any competitor worth a dime can massively cut you with a 300% markup that is insane but a steal in comparison. Then it just stabilizes to some point between where competitors need more saavy to compete and more than some minimum markup to function.

I'd say overcharge is correct given the monopolistic structure of healthcare. You don't have too many choices to begin with and it's very hard to switch.

There are many models used in different jurisdictions. Typically it's a government body for negotiation, assessment and sometimes price caps.

Health insurance profit margins are regulated, so UHC earning higher margins does seem like overcharging.

Perhaps we need antitrust action in healthcare.